Aurinia Pharmaceuticals (AUPH)
(Real Time Quote from BATS)
$5.10 USD
+0.09 (1.80%)
Updated Apr 30, 2024 10:00 AM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Aurinia Pharmaceuticals (AUPH) reported earnings of -$0.19 per share, missing the Zacks Consensus Estimate of -$0.18 per share. This reflects a negative earnings surprise of 5.56%. Look out for AUPH's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 5.56%.
Earnings History
Price & Consensus
Zacks News for AUPH
Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AUPH: What are Zacks experts saying now?
Zacks Private Portfolio Services